 |
Articles: Dosing |
Prior Articles
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions
Expert Opinion in Pharmacotherapy, 05/27/09
On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization
Vascular Pharmacology, 05/27/09 A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma
Cancer Chemotherapy and Pharmacology, 05/27/09 Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses
Antimicrobial Agents and Chemotherapy, 05/26/09 Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial
Hepatology International, 05/26/09 Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial
American Journal of Transplantation, 05/22/09 A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients
Clinical Cancer Research, 05/21/09 Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study
Clinical Therapeutics, 05/21/09 A Randomized Comparison of Azithromycin and Doxycycline for the Treatment of Mycoplasma genitalium–Positive Urethritis in Men
Clinical Infectious Diseases, 05/20/09 Pharmacokinetic properties and bioequivalence of two formulations of arbidol: An open-label, single-dose, randomized-sequence, two-period crossover study in healthy chinese male volunteers
Clinical Therapeutics, 05/20/09 Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: An open-label, single-dose, randomized, two-way crossover study in healthy chinese male volunteers
Clinical Therapeutics, 05/20/09 Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers
Clinical Therapeutics, 05/20/09 Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery
Contemporary Clinical Trials, 05/20/09 Novartis announces restructuring of global collaboration with Schering-Plough to develop fixed-dose combination respiratory therapies
Novartis, 05/20/09
Free full text
Normal-release Oral Morphine Starting Dose in Cancer Patients With Pain
The Clinical Journal of Pain, 05/20/09 Pharmacotherapy of vasculitis
Expert Opinion in Pharmacotherapy, 05/19/09 Caffeine alters proliferation of neuronal precursors in the adult hippocampus
Neuropharmacology, 05/19/09 Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation
International Journal of Neuropsychopharmacology, 05/15/09 Randomized Trial of High Dose Azithromycin Compared to Standard Dosing for Children with Severe Trachoma in Tanzania
Ophthalmic Epidemiology, 05/14/09 The Relative Potency of Inverse Opioid Agonists and A Neutral Opioid Antagonist in Precipitated Withdrawal and Antagonism of Analgesia and Toxicity
Journal of Pharmacology and Experimental Therapeutics, 05/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
